Detalhe da pesquisa
1.
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
Endocr Pract
; 26(10): 1196-1224, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471721
2.
Correction to: Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
Curr Diab Rep
; 19(11): 123, 2019 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31696328
3.
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Curr Diab Rep
; 19(12): 146, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31754844
4.
Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
Curr Diab Rep
; 19(8): 61, 2019 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332544
5.
Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?
Curr Cardiol Rep
; 20(11): 113, 2018 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30259238
6.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Endocr Pract
; 23(Suppl 2): 1-87, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28437620
7.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.
Endocr Pract
; 23(4): 479-497, 2017 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28156151
8.
Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?
Cardiovasc Diabetol
; 15: 95, 2016 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27417914
9.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.
Endocr Pract
; 26(1): 107-139, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32022600
10.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.
Endocr Pract
; 25(1): 69-100, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742570
11.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.
Endocr Pract
; 24(1): 91-120, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29368965
12.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.
Endocr Pract
; 23(2): 207-238, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28095040
13.
Do persons with diabetes benefit from combination statin and fibrate therapy?
Curr Cardiol Rep
; 14(1): 112-24, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22213157
14.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.
Endocr Pract
; 22(1): 84-113, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26731084
15.
AACE/ACE comprehensive diabetes management algorithm 2015.
Endocr Pract
; 21(4): 438-47, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25877012
16.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY.
Endocr Pract
; 21(4): 413-37, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27408942
17.
American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.
Endocr Pract
; 21 Suppl 1: 1-87, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25869408
18.
Advances in dyslipidemia management for prevention of atherosclerosis: PCSK9 monoclonal antibody therapy and beyond.
Cardiovasc Diagn Ther
; 7(Suppl 1): S11-S20, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28529918
19.
Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin.
BMJ Open Diabetes Res Care
; 4(1): e000228, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27648286
20.
Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Am J Cardiol
; 117(12): 1921-7, 2016 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27156827